Plafibride
Code | Size | Price |
---|
TAR-T28427-5mg | 5mg | £850.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T28427-50mg | 50mg | £1,661.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T28427-100mg | 100mg | £2,079.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Images
Documents
Further Information
Bioactivity:
Plafibride is an antiplatelet and antilipidemic agent.
CAS:
63394-05-8
Formula:
C16H22ClN3O4
Molecular Weight:
355.82
Purity:
0.98
SMILES:
CN(N1CCOCC1)C(=O)NC(=O)C(C)(C)Oc1ccc(Cl)cc1
References
1. Filip M, P?duraru I, Nechifor M, D?nil? GH, Popovici I, Filip FM, Po?irc? F. [The action of a fibric acid derivative on lipid metabolism]. Rev Med Chir Soc Med Nat Iasi. 1989 Jul-Sep;93(3):573-6. Romanian. PubMed PMID: 2636755.
2. D?nil? G, Nechifor M, Filip M, P?duraru I, Ifrim C, Gr?dinariu D, Papa V, Manolescu A, B?descu A. [A clofibric acid derivative with hypolipemic and platelet antiaggregant action]. Rev Med Chir Soc Med Nat Iasi. 1988 Jan-Mar;92(1):127-32. Romanian. PubMed PMID: 3393745.
3. Rodriguez F, L?pez IM, Jover E. Plafibride treatment and serum lipids in hyperlipoproteinemias. J Med. 1987;18(3-4):153-63. PubMed PMID: 3323393.
4. Joven J. [Plafibride--is it an effective drug as a hypolipemic agent?]. Med Clin (Barc). 1985 Apr 20;84(15):632. Spanish. PubMed PMID: 3999857.